Literature DB >> 21303942

Modulation of PC1/3 activity by self-interaction and substrate binding.

Akina Hoshino1, Dorota Kowalska, François Jean, Claude Lazure, Iris Lindberg.   

Abstract

Prohormone convertase (PC)1/3 is a eukaryotic serine protease in the subtilase family that participates in the proteolytic maturation of prohormone and neuropeptide precursors such as proinsulin and proopiomelanocortin. Despite the important role of this enzyme in peptide synthesis, how PC1/3 activity is regulated is still poorly understood. Using ion exchange chromatography and two-dimensional gel electrophoresis we found that natural PC1/3 present in AtT-20 cells and bovine chromaffin granules, as well as recombinant PC1/3 secreted from overexpressing Chinese hamster ovary cells, exists as multiple ionic forms. Gel filtration and cross-linking studies revealed that protein oligomerization and aggregation contribute greatly to variability in surface charge. The most acidic forms of PC1/3 contained both inactive aggregates as well as oligomerized 87-kDa PC1/3 that exhibited stable activity which was partially latent and could be revealed by dilution. No such latency was observed for the more basic, 66/74-kDa forms of PC1/3. Fractions containing these species were stabilized by preincubation with micromolar concentrations of either fluorogenic substrate or peptides containing pairs of basic residues. In addition, the most active form of 87-kDa PC1/3, a probable homodimer, was activated by preincubation with these same peptides. Cleavage by PC1/3 is often the initiating step in the biosynthetic pathway for peptide hormones, implying that this is a natural step for regulation. Our data suggest that enzyme oligomerization and peptide stabilization represent important contributing factors for the control of PC1/3 activity within secretory granules.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21303942      PMCID: PMC3060626          DOI: 10.1210/en.2010-1170

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  39 in total

1.  A predicted alpha -helix mediates targeting of the proprotein convertase PC1 to the regulated secretory pathway.

Authors:  I Jutras; N G Seidah; T L Reudelhuber
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

2.  Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.

Authors:  L D Fricker; A A McKinzie; J Sun; E Curran; Y Qian; L Yan; S D Patterson; P L Courchesne; B Richards; N Levin; N Mzhavia; L A Devi; J Douglass
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1.

Authors:  A Basak; P Koch; M Dupelle; L D Fricker; L A Devi; M Chrétien; N G Seidah
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

4.  Functional characterization of ProSAAS: similarities and differences with 7B2.

Authors:  Yolanda Fortenberry; Jae-Ryoung Hwang; Ekaterina V Apletalina; Iris Lindberg
Journal:  J Biol Chem       Date:  2001-11-21       Impact factor: 5.157

Review 5.  The radiation inactivation method as a tool to study structure-function relationships in proteins.

Authors:  G Beauregard; A Maret; R Salvayre; M Potier
Journal:  Methods Biochem Anal       Date:  1987

6.  Tissue distribution and processing of proSAAS by proprotein convertases.

Authors:  M Sayah; Y Fortenberry; A Cameron; I Lindberg
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

7.  The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1.

Authors:  Y Qian; L A Devi; N Mzhavia; S Munzer; N G Seidah; L D Fricker
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

8.  Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion.

Authors:  Martin Heni; Axel Haupt; Silke A Schäfer; Caroline Ketterer; Claus Thamer; Fausto Machicao; Norbert Stefan; Harald Staiger; Hans-Ulrich Häring; Andreas Fritsche
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

9.  Enzymatic activity of soluble and membrane tethered peptide pro-hormone convertase 1.

Authors:  Angela Bruzzaniti; Richard E Mains
Journal:  Peptides       Date:  2002-05       Impact factor: 3.750

10.  Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency.

Authors:  Robert S Jackson; John W M Creemers; I Sadaf Farooqi; Marie-Laure Raffin-Sanson; Andrea Varro; Graham J Dockray; Jens J Holst; Patricia L Brubaker; Pierre Corvol; Kenneth S Polonsky; Diane Ostrega; Kenneth L Becker; Xavier Bertagna; John C Hutton; Anne White; Mehul T Dattani; Khalid Hussain; Stephen J Middleton; Thomasina M Nicole; Peter J Milla; Keith J Lindley; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

View more
  12 in total

1.  Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Authors:  Mirella Vivoli; Thomas R Caulfield; Karina Martínez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

2.  Endoplasmic reticulum-associated degradation of the mouse PC1/3-N222D hypomorph and human PCSK1 mutations contributes to obesity.

Authors:  P Stijnen; B Brouwers; E Dirkx; B Ramos-Molina; L Van Lommel; F Schuit; L Thorrez; J Declercq; J W M Creemers
Journal:  Int J Obes (Lond)       Date:  2016-01-20       Impact factor: 5.095

3.  Purification of the proprotein convertase furin by affinity chromatography based on PC-specific inhibitors.

Authors:  Miriam Kuester; Gero L Becker; Kornelia Hardes; Iris Lindberg; Torsten Steinmetzer; Manuel E Than
Journal:  Biol Chem       Date:  2011-08-30       Impact factor: 3.915

4.  Revisiting PC1/3 Mutants: Dominant-Negative Effect of Endoplasmic Reticulum-Retained Mutants.

Authors:  Elias H Blanco; Bruno Ramos-Molina; Iris Lindberg
Journal:  Endocrinology       Date:  2015-07-24       Impact factor: 4.736

5.  Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort.

Authors:  Martín G Martín; Iris Lindberg; R Sergio Solorzano-Vargas; Jiafang Wang; Yaron Avitzur; Robert Bandsma; Christiane Sokollik; Sarah Lawrence; Lindsay A Pickett; Zijun Chen; Odul Egritas; Buket Dalgic; Valeria Albornoz; Lissy de Ridder; Jessie Hulst; Faysal Gok; Ayşen Aydoğan; Abdulrahman Al-Hussaini; Deniz Engin Gok; Michael Yourshaw; S Vincent Wu; Galen Cortina; Sara Stanford; Senta Georgia
Journal:  Gastroenterology       Date:  2013-04-02       Impact factor: 22.682

Review 6.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

7.  Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function.

Authors:  Yogikala Prabhu; Elias H Blanco; Ming Liu; Juan R Peinado; Matthew C Wheeler; Nicholas Gekakis; Peter Arvan; Iris Lindberg
Journal:  Endocrinology       Date:  2014-05-14       Impact factor: 4.736

8.  Reduced Stability and pH-Dependent Activity of a Common Obesity-Linked PCSK1 Polymorphism, N221D.

Authors:  Timothy S Jarvela; Manita Shakya; Tomas Bachor; Anne White; Malcolm J Low; Iris Lindberg
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

9.  Human Islets Contain a Beta Cell Type That Expresses Proinsulin But Not the Enzyme That Converts the Precursor to Insulin.

Authors:  Gladys Teitelman
Journal:  J Histochem Cytochem       Date:  2020-10       Impact factor: 2.479

Review 10.  Mouse Models of Human Proprotein Convertase Insufficiency.

Authors:  Manita Shakya; Iris Lindberg
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.